Host histone acetylation unlocks HDAC inhibitor potential.
作者信息
Terranova-Barberio Manuela, Thomas Scott, Munster Pamela N
机构信息
Pamela N. Munster: Department of Medicine, Division of Hematology and Oncology, Helen Diller Family Cancer Center, University of California, San Francisco, CA, USA.
出版信息
Oncotarget. 2017 Nov 13;8(63):106161-106162. doi: 10.18632/oncotarget.22422. eCollection 2017 Dec 5.
Abstract
摘要
相似文献
1
Host histone acetylation unlocks HDAC inhibitor potential.
Oncotarget. 2017 Nov 13;8(63):106161-106162. doi: 10.18632/oncotarget.22422. eCollection 2017 Dec 5.
2
Potential role of adolescent alcohol exposure-induced amygdaloid histone modifications in anxiety and alcohol intake during adulthood.
Neurobiol Dis. 2015 Oct;82:607-619. doi: 10.1016/j.nbd.2015.03.019. Epub 2015 Mar 24.
3
Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
Circ Res. 2014 Mar 28;114(7):1133-43. doi: 10.1161/CIRCRESAHA.114.303429. Epub 2014 Feb 13.
4
Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers.
Urol Oncol. 2013 Nov;31(8):1770-9. doi: 10.1016/j.urolonc.2012.06.015. Epub 2012 Sep 1.
5
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
Gastroenterology. 2006 Jun;130(7):2130-44. doi: 10.1053/j.gastro.2006.02.056.
6
Vulnerability to opiate intake in maternally deprived rats: implication of MeCP2 and of histone acetylation.
Addict Biol. 2015 Jan;20(1):120-31. doi: 10.1111/adb.12084. Epub 2013 Aug 26.
7
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.
Biochem J. 2008 Jan 15;409(2):581-9. doi: 10.1042/BJ20070779.
8
Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
Am J Physiol Renal Physiol. 2010 Jan;298(1):F133-41. doi: 10.1152/ajprenal.00400.2009. Epub 2009 Nov 11.
9
Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40.
Genes Cells. 2008 Mar;13(3):255-68. doi: 10.1111/j.1365-2443.2008.01166.x.
10
Epigenetic regulation of airway inflammation.
Curr Opin Immunol. 2007 Dec;19(6):694-700. doi: 10.1016/j.coi.2007.07.016. Epub 2007 Aug 27.
引用本文的文献
1
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.
Nat Commun. 2020 Jul 17;11(1):3584. doi: 10.1038/s41467-020-17414-y.
本文引用的文献
1
The expression of histone deacetylase HDAC1 correlates with the progression and prognosis of gastrointestinal malignancy.
Oncotarget. 2017 Jun 13;8(24):39241-39253. doi: 10.18632/oncotarget.16843.
2
Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies.
J Clin Oncol. 2017 Apr 10;35(11):1231-1239. doi: 10.1200/JCO.2016.70.5350. Epub 2017 Feb 21.
3
Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients.
Oncoimmunology. 2015 Dec 10;5(4):e1102827. doi: 10.1080/2162402X.2015.1102827. eCollection 2016 Apr.
4
Randomized phase II, double-blind, placebo-controlled study of exemestane with or without entinostat in postmenopausal women with locally recurrent or metastatic estrogen receptor-positive breast cancer progressing on treatment with a nonsteroidal aromatase inhibitor.
J Clin Oncol. 2013 Jun 10;31(17):2128-35. doi: 10.1200/JCO.2012.43.7251. Epub 2013 May 6.
5
Methods for the analysis of histone H3 and H4 acetylation in blood.
Epigenetics. 2012 Aug;7(8):875-82. doi: 10.4161/epi.20983. Epub 2012 Jul 9.
6
A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer.
Br J Cancer. 2011 Jun 7;104(12):1828-35. doi: 10.1038/bjc.2011.156. Epub 2011 May 10.
7
Phase I trial of vorinostat and doxorubicin in solid tumours: histone deacetylase 2 expression as a predictive marker.
Br J Cancer. 2009 Oct 6;101(7):1044-50. doi: 10.1038/sj.bjc.6605293. Epub 2009 Sep 8.
8
Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC.
Clin Cancer Res. 2009 Apr 1;15(7):2488-96. doi: 10.1158/1078-0432.CCR-08-1930. Epub 2009 Mar 24.
Zotero 插件